𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease

✍ Scribed by Ferenc Izbéki; Ferenc Nagy; Zoltán Szepes; Ildikó Kiss; János Lonovics; Tamás Molnár

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
123 KB
Volume
14
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Severe Legionella pneumophila pneumonia
Severe Legionella pneumophila pneumonia following infliximab therapy in a patient with Crohn's disease
✍ Florian Beigel; Matthias Jürgens; Levent Filik; Lutz Bader; Christian Lück; Burk 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

## Background: Immunosuppressive therapy with anti-tnf-alpha antibodies is effective in patients with inflammatory bowel disease (ibd). however, there is an increased risk for infections associated with this therapy. ## Methods: Here, we report the case of a 58-year-old patient with crohn's disea

Splenic function and IgM-memory B cells
Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximab
✍ Antonio Di Sabatino; M. Manuela Rosado; Paolo Cazzola; Paolo Biancheri; Francesc 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB 👁 2 views

Background: Under experimental chronic inflammation, tumor necrosis factor (TNF)-␣ plays a role in damaging spleen marginal zone. This latter has a crucial function in mounting B cell-dependent immune responses against infections by encapsulated bacteria. In Crohn's disease (CD), a chronic inflammat

Lamivudine resistance and exacerbation o
Lamivudine resistance and exacerbation of hepatitis B in infliximab-treated Crohn's disease patient
✍ Maria Esteve; Carme Loras; Ferran González-Huix 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 1 views

2004 we reported 3 cases of chronic hepatitis B in Crohn's disease (CD) patients from a cohort of 80 patients treated with infliximab. 1 Two patients showed severe reactivation, 1 of whom died. Based on the American Association for the Study of Liver Disease (AASLD) and European guidelines, 2,3 pree